We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type

70 results found


Gowling WLG | Canada | 30 Nov 2016

Federal Court of Appeal grants minister of health the right to be wrong

In an October 12 2016 decision (Teva Canada Limited v Pfizer Canada Inc, 2016 FCA 248) the Federal Court of Appeal upheld two decisions of the


Lathrop Gage LLP | USA | 6 Jul 2011

CAFC invalidates claims covering specified dose range as obvious

On June 22, 2011, the Court of Appeals for the Federal Circuit (CAFC) upheld a summary judgment invalidating two claims of U.S. Patent No. 5,211,954 (“the ‘954 patent”), which covers a pharmaceutical formulation comprising particular doses of a sleep-inducing agent.


Hogan Lovells | Spain | 14 Oct 2010

Spanish Supreme Court rules on Bolar and experimental research exemption

In a decision of 30 June 2010, the Spanish Supreme Court ruled that the Bolar provision implemented in Spain in July 2006 did not have a retroactive effect.


McMillan LLP | Canada | 7 Oct 2010

Innovator duty of care in the pharmaceutical industry

Does the inventor or "innovator" of a brand-name drug have a duty of care to the consumers of that drug's generic equivalent manufactured by a competitor?

Previous page 1 2 3 ...